Phoebe Evans1, Bernard Siow1,2, Ian Harrison1, Ozama Ismail1, Yolanda Ohene1, Payam Nahavandi 1, David Thomas3,4, Mark Lythgoe1, and Jack Wells1
1Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, United Kingdom, 2The Francis Crick Institute, London, United Kingdom, 3Neuroradiological Academic Unit, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, London, United Kingdom, 4Leonard Wolfson Experimental Neurology Centre, UCL Queen Square Institute of Neurology, London, United Kingdom
Synopsis
Within the glymphatic
system, CSF is transported in a network of perivascular channels where it
exchanges with ISF to drive drainage of unwanted solutes, like amyloid- β, out
of the brain. Perivascular channel impairment may be an early biomarker of
neurodegenerative processes. Here, we present a pilot study for 3D non-invasive
assessment of glymphatic function in the rat brain using ultra-long echo time
diffusion MRI. We show that this technique is sensitive to the fluid movement
in downstream perivascular channels that drives glymphatic inflow.
Introduction
Efficient waste removal
from the brain is essential to maintain normal physiology and function$$$^{1}$$$. The glymphatic pathway describes a network
of perivascular channels that facilitate rapid cerebrospinal fluid (CSF) transport
and exchange with the brain’s interstitial fluid (ISF), for parenchymal waste
clearance$$$^{2}$$$. The continuous interchange
between CSF and ISF washes unwanted solutes towards larger central veins and
lymphatic vessels to eventually be removed from the CNS$$$^{3}$$$. Thus, perivascular channels play a crucial
role in CSF-mediated clearance of potentially toxic molecules, such as
amyloid-β$$$^{4}$$$. Perivascular channel impairment may lead to a build-up
of toxic molecules in the aging brain and eventually, the onset of neurodegenerative
diseases such as Alzheimer’s disease (AD). As such, the perivascular space (PVS) represent a promising target
for non-invasive imaging biomarkers of glymphatic function. Recently, we have
introduced the first non-invasive technique to assess the glymphatic pathway
using ultra-long echo time (TE) diffusion-weighted MRI sequences in the rat
brain$$$^{5}$$$. This technique captured the dynamics of CSF movement within
the PVS of an upstream glymphatic target; the middle cerebral artery (MCA) at
the base of the rat brain. Moreover, the application of this technique was
limited to single slice 2D acquisitions which restricted the measurement to a
small segment of the glymphatic pathway. Here, we use a 3D acquisition working
towards whole brain mapping of PVS function across the glymphatic network of
the rat brain. As such, in this pilot study, we examine more downstream segments
of PVS anatomy, closer to the eventual site of CSF delivery to the tissue. In
addition, we investigate whether cardiac cycle-related vessel pulsatility changes
the recorded PVS fluid movement during arterial pulsation and diastole. Methods
A healthy male Sprague Dawley rat was anaesthetised
and scanned on an Agilent 9.4T
system (free-breathing, 2%
isoflurane in 0.2L/min medical air and 0.8L/min O2).
Diffusion-Weighted
Imaging: An imaging volume was positioned at the base of the brain (see
Figure 1A). A fast-spin-echo 3D diffusion weighted sequence was acquired with
the following sequence parameters: TR = 4s, effective TE = 133ms, echo train
length = 32, echo spacing = 11ms, FOV
= 30mm x 30mm x 8mm, matrix (RO x PE x PE2) = 192
x192 x 16, 4 averages, b0 + one direction (ventrodorsal), b-value = 43 s/$$$mm^{2}$$$.
ECG-Gating: A three lead
electrode was used to measure ECG signals in the bore of the magnet. Image
acquisition was gated to the ECG signal to capture fluid movement in PVS during
vessel pulsation and diastole. As such, image acquisition began either directly
after the R-wave (i.e. during pulsation) or with a 120ms delay (i.e. during
diastole).
Analysis: Region of
interests were manually drawn around the PVS surrounding the left and right
branches of the MCA at the ventral and dorsal aspects of the blood vessel (see
Figure 1A).
The pseudo-diffusion coefficient (D*) was then calculated using
the following equation:
$$S = S0 exp(-bD*)$$
where S is the measured signal at b=43s/$$$mm^{2}$$$ and S0 is the signal taken from the
b=0 image.
Results
Figure 1A shows a schematic of the rat brain in both axial and
sagittal orientations. These show the origin of the MCA from the base of the
brain near the circle of Willis (CoW) and where it branches symmetrically
around the rostral-lateral outer edges of the brain. Figure 1C shows the pseudo-coefficient
(D*) maps from the upstream (green) and more downstream (purple) targets of the
PVS surrounding the MCA during arterial pulsation (0ms) and diastole (120ms). The D* maps and graph in
Figure 1B show, in this animal, that perivascular
fluid in both regions of the MCA has a greater D* during arterial pulsation
compared to diastole. Moreover, the recorded D* values of the downstream PVS
compartment are consistent with our previous characterisation of the PVS around
the ventral aspect of the MCA, providing preliminary evidence that we are successfully
capturing PVS fluid movement at a more downstream target within the glymphatic pathway. Discussion
In this pilot study, we
have non-invasively assessed fluid movement in a downstream compartment of the PVS
in the rat brain. We have preliminary evidence to suggest
that arterial pulsation may drive fluid movement in the PVS and could be a
major contributor to glymphatic inflow. This technique could serve as a
potential early biomarker of perivascular impairment and therefore
neurodegenerative diseases such as AD.Acknowledgements
This work
is supported by the Medical Research Council (MR/K501268/1) and the
EPSRC-funded UCL Centre for Doctoral Training in Medical Imaging (EP/L016478/1)
together with the Wellcome Trust and Royal Society. DT is supported by the UCL Leonard Wolfson
Experimental Neurology Centre (PR/ylr/18575).References
[1] Jessen, N., Munk, A., Lundgaard, I. and
Nedergaard, M. (2015). The Glymphatic System: A Beginner’s Guide. Neurochemical
Research, 40(12), pp.2583-2599.
[2] Benveniste, H., Liu, X., Koundal, S.,
Sanggaard, S., Lee, H. and Wardlaw, J. (2018). The Glymphatic System and Waste
Clearance with Brain Aging: A Review. Gerontology, pp.1-14.
[3] Hladky SB, Barrand MA. Mechanisms of fluid
movement into, through and out of the brain: evaluation of the evidence. Fluids Barriers CNS. 2014;11(26):1–32.
[4] Peng, W., Achariyar, T., Li, B., Liao, Y.,
Mestre, H., Hitomi, E., Regan, S., Kasper, T., Peng, S., Ding, F., Benveniste,
H., Nedergaard, M. and Deane, R. (2016). Suppression of glymphatic fluid
transport in a mouse model of Alzheimer's disease. Neurobiology of
Disease, 93, pp.215-225.
[5] Harrison, I., Siow, B., Akilo,
A., Evans, P., Ismail, O., Ohene, Y., Nahavandi, P., Thomas, D., Lythgoe, M.
and Wells, J. (2018). Non-invasive imaging of CSF-mediated brain clearance
pathways via assessment of perivascular fluid movement with diffusion tensor
MRI. eLife, 7.
[6] Rodríguez-Contreras,
A., Shi, L. and Fu, B. (2014). A Method to Make a Craniotomy on the Ventral
Skull of Neonate Rodents. Journal of Visualized Experiments, (87).